This factoid shows a problem that hasn’t been addressed sufficiently:
Covid vaccination rate in the U.S. among age >65:
First dose 95% (good; though in other countries it’s 98% or higher)
Second dose 91% (fair; in other countries it’s 98% or higher)
First booster 58% (poor; in other countries it’s 85% or higher)
Second booster 18% (really poor; especially in vulnerable sub-populations; in other countries it’s 45% or higher)
I’m surprised that folks who had 1 and 2 didn’t get 3. Four doesn’t surprise me. I had 1 and 2 as soon as I could. Eight months then was recommended between 2 and 3. That put me at December 1 for 3.
I’m holding on 4 as I explained a bit ago. I have my yearly pcp appt today and this is something I plan to discuss. But I doubt he will change my mind.
Joshua, our rollout was horrific. Could that post a part. Following guidance by experts I’ve come to trust, I’m still in the 8 month window for 4
Philip. I get why N95s are not comfortable. I also have trouble. I found this and wonder if it might help you with an alternative
Vicki, I completely understand your decision not to get the 2nd booster yet. And indeed many >65 in other countries (55%) haven’t gotten their 2nd booster; probably for similar reasons. But, there are many vulnerable folks who really should have gotten their 2nd booster and haven’t. Worse is, of course, the 58% figure for 1st booster; 42% haven’t gotten a 1st booster. That’s quite low.
I of course wasn’t clear ….nothing new. It was the first booster number (vaccine 3) that really surprised me. If someone was concerned enough to have one and two, it is curious why he/she would not have three.
For #4, I was just speculating on reasons.
Philip, as I wait for my pcp, I sure understand why you can’t wear an N 95 for long periods.
Adding. Interesting that all staff here are wearing surgical.
The drug remains important for high-risk patients, but even there the data are NOT showing the kinds of results Pfizer was touting in December 2021.
You may recall how upset I was with Pfizer for essentially advertising Paxlovid as an elixir, based on very preliminary data. I was skeptical then of the data and did not believe the drug was a major breakthrough. I also said at the time I do not think the FDA or U.S. government should allow companies to promote products with preliminary data that are either in Phase 3 (last phase before approval) or early after approval; especially when it’s the CEO who’s doing the promoting (he is NOT a clinical scientist).
I sure do recall your skepticism and agreed with it at the time. Unfortunately, I’ve heard far too often now that folks can pretty much stop worrying about Covid because we have have the vaccines and we have paxlovid.
That is exactly what the premature promotion has done.
I just read that Dr. Fauci has tested positive for COVID.
You can add Mick Jagger of The Rolling Stones as well.
C-19
6-16
ready
Comments are closed.
Your no-hype southeastern New England weather blog!
This factoid shows a problem that hasn’t been addressed sufficiently:
Covid vaccination rate in the U.S. among age >65:
First dose 95% (good; though in other countries it’s 98% or higher)
Second dose 91% (fair; in other countries it’s 98% or higher)
First booster 58% (poor; in other countries it’s 85% or higher)
Second booster 18% (really poor; especially in vulnerable sub-populations; in other countries it’s 45% or higher)
I’m surprised that folks who had 1 and 2 didn’t get 3. Four doesn’t surprise me. I had 1 and 2 as soon as I could. Eight months then was recommended between 2 and 3. That put me at December 1 for 3.
I’m holding on 4 as I explained a bit ago. I have my yearly pcp appt today and this is something I plan to discuss. But I doubt he will change my mind.
Joshua, our rollout was horrific. Could that post a part. Following guidance by experts I’ve come to trust, I’m still in the 8 month window for 4
Philip. I get why N95s are not comfortable. I also have trouble. I found this and wonder if it might help you with an alternative
https://nymag.com/strategist/article/best-face-mask-filters.html
Vicki, I completely understand your decision not to get the 2nd booster yet. And indeed many >65 in other countries (55%) haven’t gotten their 2nd booster; probably for similar reasons. But, there are many vulnerable folks who really should have gotten their 2nd booster and haven’t. Worse is, of course, the 58% figure for 1st booster; 42% haven’t gotten a 1st booster. That’s quite low.
I of course wasn’t clear ….nothing new. It was the first booster number (vaccine 3) that really surprised me. If someone was concerned enough to have one and two, it is curious why he/she would not have three.
For #4, I was just speculating on reasons.
Philip, as I wait for my pcp, I sure understand why you can’t wear an N 95 for long periods.
Adding. Interesting that all staff here are wearing surgical.
Problematic data that show little or no improvement regarding Pfizer’s Paxlovid: https://twitter.com/VincentRK/status/1537095755378216960
The drug remains important for high-risk patients, but even there the data are NOT showing the kinds of results Pfizer was touting in December 2021.
You may recall how upset I was with Pfizer for essentially advertising Paxlovid as an elixir, based on very preliminary data. I was skeptical then of the data and did not believe the drug was a major breakthrough. I also said at the time I do not think the FDA or U.S. government should allow companies to promote products with preliminary data that are either in Phase 3 (last phase before approval) or early after approval; especially when it’s the CEO who’s doing the promoting (he is NOT a clinical scientist).
I sure do recall your skepticism and agreed with it at the time. Unfortunately, I’ve heard far too often now that folks can pretty much stop worrying about Covid because we have have the vaccines and we have paxlovid.
That is exactly what the premature promotion has done.
I just read that Dr. Fauci has tested positive for COVID.
You can add Mick Jagger of The Rolling Stones as well.
C-19
6-16
ready